Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2003
09/04/2003US20030166931 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166930 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166697 Divalent aromatic heterocyclic compounds useful in prevention or treatment of hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity, and the like
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166668 Substituted heteroarylalkanoic acids
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003US20030166578 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
09/04/2003CA2479812A1 Glutaminyl based dpiv inhibitors
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2475299A1 Thiazole derivatives as npy receptor antagonists
09/04/2003CA2474793A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1340751A1 Process for producing anhydride of aminothiazole derivative
09/03/2003EP1340750A1 Amide derivatives
09/03/2003EP1340746A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1077961B1 Process for the manufacture of a sulfenimide
09/03/2003EP0783496B9 Thiazolidinedione derivatives, their production and use
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440391A Propane-1,3-dione derivatives
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1439635A SW diaryl ethylene compounds and preparation and application thereof
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/03/2003CN1119987C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/02/2003US6614719 Ultrasonic doppler effect speed measurement
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613912 Useful as drugs or protecting plants
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613783 Non-systemic control of parasites
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070682A1 NON-COVALENT INHIBITORS OF AmpC ß-LACTAMASE
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070239A1 Benzylidene thiazolidinediones and their use as antimycotic agents
08/28/2003WO2003070238A1 Thiazolidine antifungal agents
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003US20030162820 Heterocyclic amides used as dipeptidyl aminopeptidase (DPIV) inhibitors, for prophylaxis of arthritis, obesity, allograft surgery, cancer, autoimmune, nervous system and skin disorders
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/27/2003EP1338589A1 Organic compound having cyano group and insecticides/miticides
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337234A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1261593B1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
08/27/2003EP1195375B1 Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
08/27/2003EP1087975B1 Epothilone minor constituents
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0842157B1 Herbicidal sulphonylamino(thio)carbonyl compounds
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/26/2003US6610857 Process for the production of dithiazolyl disulfides
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610846 Heteroaromatic glucokinase activators
08/26/2003US6610791 Photosensitive compound and photosensitive resin
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610734 Heterocyclic sulfonamide inhibitors of beta amyloid production
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610714 Non-nucleoside reverse transcriptase inhibitors
08/26/2003US6610696 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
08/22/2003CA2372731A1 Oligo-amine/oligo-carboxy sulfonamides
08/21/2003WO2003069411A1 Visible radiation sensitive composition
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068725A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
08/21/2003WO2003068269A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques
08/21/2003WO2003068227A1 5-ht2b receptor antagonists
08/21/2003WO2002032844A8 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158406 Enzyme inhibitor treating autoimmune diseases, Alzheimer's disease, atherosclerosis
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158241 Used for treatment of diabetes and a complication thereof, hyperlipidemia and a complication thereof, hyperuricemia, leukemia, and pancreatitis.
08/21/2003US20030158231 Sulfonamide compounds as protease inhibitors
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158199 Novel compounds for inhibition of Tie-2
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant
08/21/2003CA2474411A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques
08/21/2003CA2472763A1 5-ht2b receptor antagonists
08/20/2003EP1336607A1 Amide derivatives as glucokinase activators